OCUNEXUS THERAPEUTICS

ocunexus-therapeutics-logo

Ocunexus Therapeutics is a biopharmaceutical company that develops therapeutics for unmet clinical needs in ophthalmology. The company specializes in developing highly differentiated drug candidates based upon a novel mechanism of action called “Gap Junction Channel Modulation.” It has developed treatments for multiple front- and back-of-the-eye diseases and disorders that would potentially alter the standard of care. In addition, the company's technologies are expected to be transferable to other acute and chronic disease indications. Ocunexus is formerly known as CoDa Therapeutics, a pharmaceutical company focused on the development and commercialization of wound care therapeutics based on gap junction modulation. The company is based in San Diego, California.

#SimilarOrganizations #People #Financial #Website #More

OCUNEXUS THERAPEUTICS

Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics

Founded:
2005-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.ocunexus.com

Total Employee:
1+

Status:
Closed

Contact:
(858) 677-0474

Email Addresses:
[email protected]

Total Funding:
78.59 M USD


Similar Organizations

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.


Current Advisors List

geoff-brooke_image

Geoff Brooke Board of Directors @ Ocunexus Therapeutics
Board_member

jim-blair_image

Jim Blair Board of Directors @ Ocunexus Therapeutics
Board_member

howard-ted-greene_image

Howard (Ted) Greene Board of Directors @ Ocunexus Therapeutics
Board_member

anula-md-phd-mba-jayasuriya_image

Anula , MD, PhD, MBA, Jayasuriya Member of the Board of Directors @ Ocunexus Therapeutics
Board_member

Current Employees Featured

brian-levy_image

Brian Levy
Brian Levy CEO @ Ocunexus Therapeutics
CEO

david-e-eisenbud_image

David E. Eisenbud
David E. Eisenbud Chief Medical Officer @ Ocunexus Therapeutics
Chief Medical Officer

david-pool_image

David Pool
David Pool Chief Financial Officer @ Ocunexus Therapeutics
Chief Financial Officer

colin-green_image

Colin Green
Colin Green Chief Scientist @ Ocunexus Therapeutics
Chief Scientist
2016-01-01

alexis-white_image

Alexis White
Alexis White Clinical Research Manager @ Ocunexus Therapeutics
Clinical Research Manager

Founder


bradford-j-duft_image

Bradford J. Duft

colin-green_image

Colin Green

david-becker_image

David Becker

Investors List

biopacific-ventures_image

BioPacific Ventures

BioPacific Ventures investment in Series B - Ocunexus Therapeutics

rmi-partners_image

RMI Partners

RMI Partners investment in Series B - Ocunexus Therapeutics

gbs-ventures_image

GBS Ventures

GBS Ventures investment in Series B - Ocunexus Therapeutics

domain-associates_image

Domain Associates

Domain Associates investment in Series B - Ocunexus Therapeutics

square-1-bank_image

Square 1 Bank

Square 1 Bank investment in Debt Financing - Ocunexus Therapeutics

biopacific-ventures_image

BioPacific Ventures

BioPacific Ventures investment in Series B - Ocunexus Therapeutics

gbs-ventures_image

GBS Ventures

GBS Ventures investment in Series B - Ocunexus Therapeutics

domain-associates_image

Domain Associates

Domain Associates investment in Series B - Ocunexus Therapeutics

domain-associates_image

Domain Associates

Domain Associates investment in Series A - Ocunexus Therapeutics

gbs-ventures_image

GBS Ventures

GBS Ventures investment in Series A - Ocunexus Therapeutics

Official Site Inspections

http://www.ocunexus.com

  • Host name: new3.isexpired.net
  • IP address: 178.128.239.245
  • Location: Toronto Canada
  • Latitude: 43.6547
  • Longitude: -79.3623
  • Timezone: America/Toronto
  • Postal: M5A

Loading ...

More informations about "Ocunexus Therapeutics" on Search Engine